# Prevention of donation-related infections: investigating the use of antibiotics in the decontamination of preservation fluid for organ transplantation

**Authors:** Yazhe Duan, Junhao Yu, Pei Zhang, Yuhong Li, Kewen Chen, Yanfeng Li, Yuxiang Wan, Kang Wu, Li Zeng, Yanhua Li, Mingxing Sui

PMC · DOI: 10.3389/fcimb.2025.1572799 · Frontiers in Cellular and Infection Microbiology · 2025-07-23

## TL;DR

This study investigates how adding antibiotics to organ preservation fluid can prevent dangerous infections during organ transplants.

## Contribution

The study compares the effectiveness of different antibiotics in decontaminating preservation fluid to prevent carbapenem-resistant gram-negative bacterial infections.

## Key findings

- Polymyxin B and colistin sulfate showed better antimicrobial effectiveness against CRGNB than amikacin and colistimethate sodium in cold preservation fluid.
- The antimicrobial effect of colistimethate sodium improved significantly after pretreatment at 4°C.
- Decontamination regimens using polymyxin B or colistin sulfate are effective in preventing donation-related infections.

## Abstract

Donation-related infections (DRIs), particularly those caused by carbapenem-resistant gram-negative bacteria (CRGNB), can have disastrous consequences because of their extensive drug resistance. Contamination during graft acquisition and transport can lead to DRIs, and the use of antibiotics in preservation fluid (PF) before organ transplantation can reduce the incidence of DRIs. This study was to determine and compare the effectiveness of different PF decontamination regimens to prevent CRGNB related DRIs.

Twelve CRGNB strains were chosen to be the targets of decontamination, and a drug concentration gradient was established for each test drug based on the previous clinical research. In addition the standard decontamination procedures were performed to evaluate the antimicrobial effectiveness of polymyxin B (PB), colistin sulfate (CS), colistimethate sodium (CMS) and amikacin (AK) in the 0~4°C PF, and to explore the antimicrobial effects of CMS after different preprocessing methods.

PB and CS exhibited significantly better antimicrobial effectiveness against CRGNB than AK and CMS in the 0~4°C PF, and the antimicrobial effects on CRGNB increased with the increasing concentration of drugs. Notably, CMS after pretreatment (CMS-AP), its antibacterial was significantly enhanced at 4°C.

The PF decontamination is important in preventing the DRIs caused by CRGNB, and the decontamination regimens based on PB or CS were confirmed effective. Notably, CMS could even achieve a better decontamination effect than PB after a simple and fast pretreatment.

## Linked entities

- **Chemicals:** colistin sulfate (PubChem CID 73090), colistimethate sodium (PubChem CID 44585614), amikacin (PubChem CID 37768)

## Full-text entities

- **Diseases:** DRIs (MESH:D007239)
- **Chemicals:** carbapenem (MESH:D015780), AK (MESH:D000583)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12325265/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12325265/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12325265/full.md

---
Source: https://tomesphere.com/paper/PMC12325265